Matthias T. Stephan MD, PhD

Dr. Stephan joined the Clinical Research Division at Fred Hutchinson Cancer Research Center (FHCRC) as Assistant Member in 2012 to establish a research program that will steer the implementation of next-generation ovarian cancer therapies derived from smart biomaterials and nanotechnology. During his postdoctoral training at the Massachusetts Institute of Technology, Dr. Stephan specialized in synthesizing and applying synthetic material to manipulate immune cells (Nat. Med. 2010 Sep). Coupled with his PhD training in tumor immunology at Cornell University.
Dr. Stephan in an excellent position to develop novel bioengineering approaches for safe and effective ovarian cancer therapy. In recognition of the success he has already achieved, which has been highlighted in a number of reviews, Dr. Stephan was recognized with the “Future Leader in Translational Medicine Award” by the American Academy for Cancer Research, and the Ruth L. Kirschstein National Research Service Award from the National Institutes of Health.